Protection

Key molecule in plant photo-protection identified

Brain cells in a mouse model of Alzheimer'sdisease have surprised scientists with their ability to recuperateafter the disorder's characteristic brain plaques are removed.Researchers at Washington University School of Medicine in St. Louisinjected mice with an antibody for a key component of brain plaques,the amyloid beta (Abeta) peptide. In areas of the brain whereantibodies cleared plaque...

Sickle cell and protection against malaria

In this month's issue of the freely available online journal PLoS Medicine, Dr. Thomas N. Williams and colleagues from Kilifi, Kenya, show that the protection against malaria given by carrying the gene for sickle cell haemoglobin may involve the immune system. Studying a group of children and adults in the Kilifi District of coastal Kenya, they found that this protection increased during childhoo...

U.N. mulls the protection of Earth's forests

The final meeting of the United Nations Forum on Forests, now under way, could result in firm commitments to protect the world's forests or, some environmentalists worry, merely an agreement to continue negotiations. One member of the U.S. delegation to the U.N. forum is international environmental policy expert Matthew Auer, who remains guardedly optimistic that the two-week negotiation...

UNC plant researchers discover proteins interact to form hair-trigger protection against invaders

Experimenting with Arabidopsis, a fast-growing cousin of the humble mustard plant, scientists at the University of North Carolina at Chapel Hill got a big surprise while investigating how plants respond to attacks from disease organisms such as bacteria and viruses. "Contrary to what we thought we'd find, our experiments showed that at least three different proteins work in concert with on...

Researchers Find Drug May Give Some Cardiac Protection 24 Hours After Heart Attack

A drug has been shown to provide some protection to the heart from injury even if given as much as 24 hours after a heart attack, Jefferson Medical College researchers report. Walter Koch, Ph.D., director of the Center for Translational Medicine in the Department of Medicine at Jefferson Medical College of Thomas Jefferson University in Philadelphia, and his co-workers knew that the drug D...

More>>

Protection at Biology Products

EPA II Peroxidase Protection Buffer from CHEMICON

Description:EPA II Buffer is a diluent formulated to stabilize the activity of Chemicon horseradish peroxidase (HRP)-antibody conjugates at high conjugate dilution for extended periods....
Company:CHEMICON

Protection at Biology Technology

Nuclease Protection Assays: The Basics

<A href="#1">What is an NPA? <A href="#2">Advantages > <A href="#3">Limitations > <A href="#4">Steps <br...

Protector RNase Inhibitor Enhance the Protection of RNA against Degradation

Is a new type of RNase inhibitor and inhibits a wide known spectrum ofRNases. Does not interfere with the performance of enzymes in an assay - evenwhen high amounts (e.g., up to 16-fold the standard concentr...

RNase Protection Assay (RPA) Using DIG-Labeled RNA Probes

The ribonuclease protection assay (RPA) is a highly sensitiveand specific method for the detection and quantitationof mRNA species. The assay was made possibleby the discovery and characterization of bacteriophageencodedDNA-dependent RNA polymerases (SP6, T7,and T3)....

Brand protection in the age of customer engagement

Brands of every sort - from the globally familiar to the local politician du jour - are being savaged, attacked, extolled, and venerated with a speed never seen before. The digital tools of our age provide numerous new channels for brand commentary, both positive and negative, and these multiplying channels place daunting new demands on corporate and political brand...

MailFoundry offers new spam protection products

The e-mail hosting and filtering solutions provider offers network products like that attempt to protect...

More>>

Protection at Medicine News

Relating heart protection and antihypertensive drugs

Maintaining a normal blood pressure is essential in the prevention of heart disease and is controlled by antihypertensive drugs, say researchers. Dr Jan Staessen and colleagues from Leuven, in Belgium, set out to determine whether it is the pharmacological properties of antihypertensive drugs or the reduction of blood pressure that accounts for the cardiovascular outcome in hypertensive patients....

Protection mechanism of fatty acids for Cancer

A recent study by researchers at the University of Texas, have found out how omega-3 fatty acids might protect against colon cancer.Omega-3 fatty acids, which are found in fish oil, have long been known to protect against colon cancer.// They learned that the omega-3s block a molecule called protein kinase C beta II (PKCbII) - which is linked with abnormal cell division. In this study,...

Tennis gives protection against heart disease lifelong

Researchers at the University of Hopkins University, men who keep up playing tennis throughout life are less prone to have a heart attack than those who are less active. They have been following a group of medical students at college during 1950 and 1960. //They asked them about participation in tennis, golf, football, baseball and basketball. Those who reported the greatest skill in tennis were...

Heart failure protection through gene therapy

The causes of heart failure are many including genetic abnormalities. Earlier studies have shown that malfunctioning of a gene called phospholamban contributes to heart failure and this discovery is now being used as a basis for a gene therapy approach in protecting against heart failure. The research which was carried out on hamsters born predisposed to heart failure showed that deliv...

Protection from Dementia

Stroke patients who take two common blood pressure medications are less likely to suffer dementia or cognitive decline if they have another stroke, finds a new study in this month’s Archives of Internal Medicine. Dementia is a major health concern in developed nations, ranking as the eighth leading cause of death and disability. Studies have shown elevated blood pressure levels and prior i...

More>>

Protection at Medicine Products

BD Visitec Eye Protection Products

Description:Universal, clear, lightweight plastic with smooth edges & ventilation holes for patient comfort...
Company:BD Ophthalmics

Proxis Embolic Protection System

Description:Proxis features 'proximal protection' -- providing complete protection from initial crossing to device removal, even in vessels with side branches. Proxis is fast and easy to use. It does not require the attachment or exchange of extra devices for removal of embolic debris. Proxis is compatible with all standard PTCA guidewires. Deployment, capture and recovery are quick a...
Company:Velocimed, Inc.

FilterWire EZ Embolic Protection System

Description:Predictable Protection Made Easy. The new generation FilterWire EZ System has focused improvements on effectiveness and ease of use, providing you with the confidence of greater predictability for SVG stenting and angioplasty procedures. The FilterWire EZ System adds predictability to the procedure while requiring minimal changes to technique. The filter loop provides protection in a bro...
Company:Boston Scientific Corporation

RX ACCUNET Embolic Protection System

Description:The RX ACCUNET Embolic Protection System is designed to provide excellent capture capabilities and easy filter control when performing carotid stenting interventions. The ACCUNET is a .014 guide wire based filter system that utilizes rapid exchange technology so that the physician can easily control the filter during catheter manipulations. It is available in both 190 cm and 300 cm lengths with t...
Company:Guidant Corporation

T4 Personal Protection System

Description:Stryker Instruments, the leader in surgical helmets, offers its 4th generation of personal protection systems for todays surgical environment the Sterishield T4 System....
Company:Stryker Instruments

More>>

Protection at Medicine Technology

Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types

Results also show significant additional protection againstinfection with virus types beyond 16 and 18 with the GSK cervicalcancer candidate vaccine PHILADELPHIA, June 27, 2007 /PRNewswire-FirstCall/ -- Resultsfrom an interim analysis of a Phase III study show thatCERVARIX(R), the GlaxoSmithKline cervical cancer candidate vaccine,provides up to 100 percent protection against advanced prec...

Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal Challenge of Live Virus, Pre-Clinical Data Show

Study Presented at Second International Conference on AvianInfluenza at France's Pasteur Institute PARIS, June 01, 2007 /PRNewswire-FirstCall/ -- Very low doses ofNovavax Inc.'s pandemic influenza vaccine provided protectionagainst a lethal challenge of live H5N1 viruses, according topre-clinical data presented here today at the Second InternationalConference on Avian Influenza in Humans....

Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term Protection and Sterilizing Immunity in Nonhuman Primates

SEATTLE, May 31, 2007 /PRNewswire-FirstCall/ -- VicalIncorporated today announced that a measles DNA vaccine formulatedwith the company's Vaxfectin(TM) adjuvant elicited protectivelevels of neutralizing antibodies in juvenile (1 - 2 year old)nonhuman primates confirmed by complete protection followingchallenge more than one year after vaccination, and sterilizingimmunity as evidenced by...

VGX Pharmaceuticals' Novel HIV and Pandemic Influenza DNA Vaccine Candidates Trigger Robust Immune Responses and Protection in Pre-Clinical Models

MALAGA, Spain--(BUSINESS WIRE)--May 23, 2007 - VGX Pharmaceuticals'novel pandemic influenza vaccine candidates triggered protectiveimmune responses in pre-clinical challenge studies, according todata presented for the first time today at the Third InternationalConference on DNA Vaccines in Malaga, Spain. VGX scientists created four synthetic consensus DNA vaccines toprotect against a leth...

LigoCyte Pharmaceuticals Presents Data Showing Heterosubtypic Protection Against Influenza Challenge With Virus-Like Particle Immunization

BOZEMAN, Mont., May 01, 2007 /PRNewswire/ -- LigoCytePharmaceuticals presented preclinical data today showing thatimmunization with their influenza virus-like particles (VLPs)induced heterosubtypic protection in a virus challenge study. Thecompany's data were presented by Dr. Joel Haynes, LigoCyte's seniordirector of vaccine development, at the Tenth Annual Conference onVaccine Research...

More>>